{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:28:11Z","timestamp":1771363691637,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective of this study is to find the organism profile and antimicrobial susceptibility patterns in children with cystic fibrosis (CF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Prospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Hospital-based study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>Sputum cultures\/throat swabs were collected from the study population. Relevant details like anthropometry, systemic examination findings and investigations were entered in a pre-designed format. Sputum culture was subjected to microbiological analysis at the hospital microbiology laboratory.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measure<\/jats:title>\n                  <jats:p>Prevalence of positive sputum\/cough swab culture in CF patients, their organism profile and antibiotic sensitivity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 63 patients were enrolled in the study. A total of 136 organisms were grown in our study population. Thirteen different organisms were isolated, which included five gram-positive bacteria, six gram-negative bacteria, eight Candida spp. and one filamentous. Antibiotic sensitivity profile of the Pseudomonas aeruginosa showed excellent sensitivity to all the aminoglycosides, piperacillin-tazobacteum and polymixin, similarly methicillin-sensitive Staphylococcus aureus, methicillin-resistant S. aureus and Enterococcus spp. were uniformly sensitive to vancomycin, linezolid and teicoplanin. Fungal isolates showed 100% sensitivity to all the antifungals tested including azoles and amphotericin B.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We observed 61% of culture positivity for different organisms in our study. Staphylococcus aureus and P. aeruginosa were the most frequently isolated organisms. Pseudomonas aeruginosa isolates were largely sensitive to aminoglycosides, carbapenems and polymixin. We found an unusually higher incidence of enterococcal infection in our study cohort with few vancomycin-resistant isolates.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/tropej\/fmab030","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T19:40:38Z","timestamp":1617824438000},"source":"Crossref","is-referenced-by-count":5,"title":["Airway Microbiology in Children with Cystic Fibrosis: A Prospective Cohort Study from Northern India"],"prefix":"10.1093","volume":"67","author":[{"given":"Gulnaz","family":"Bashir","sequence":"first","affiliation":[{"name":"Department of Microbiology, SKIMS, Soura, Jammu and Kashmir 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4094-4634","authenticated-orcid":false,"given":"Javeed Iqbal","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, SKIMS, Soura, Jammu and Kashmir 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sozia","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Microbiology, SKIMS, Soura, Jammu and Kashmir 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashir Ahmad","family":"Fomda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, SKIMS, Soura, Jammu and Kashmir 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nargis K","family":"Bali","sequence":"additional","affiliation":[{"name":"Department of Microbiology, SKIMS, Soura, Jammu and Kashmir 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Insha","family":"Altaf","sequence":"additional","affiliation":[{"name":"Department of Microbiology, SKIMS, Soura, Jammu and Kashmir 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"2021072816523306800_fmab030-B1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","article-title":"The incidence of cystic fibrosis","volume":"15","author":"Kosorok","year":"1996","journal-title":"Stat Med"},{"key":"2021072816523306800_fmab030-B2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"key":"2021072816523306800_fmab030-B3","first-page":"2793","volume-title":"Congenital Lung Malformations","author":"Bush","year":"2019","edition":"9th edn"},{"key":"2021072816523306800_fmab030-B4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li","year":"2005","journal-title":"JAMA"},{"key":"2021072816523306800_fmab030-B5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1099\/jmm.0.46884-0","article-title":"Multidrug-resistant pulmonary infection in cystic fibrosis\u2013what does \u2018resistant\u2019 mean?","volume":"55","author":"Govan","year":"2006","journal-title":"J Med Microbiol"},{"key":"2021072816523306800_fmab030-B6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.01510-06","article-title":"Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease","volume":"45","author":"Besier","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2021072816523306800_fmab030-B7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1099\/jmm.0.05069-0","article-title":"Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection","volume":"52","author":"H\u00e4u\u00dfler","year":"2003","journal-title":"J Med Microbiol"},{"key":"2021072816523306800_fmab030-B8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"2021072816523306800_fmab030-B9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ppul.1144","article-title":"Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis","volume":"32","author":"Rosenfeld","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"2021072816523306800_fmab030-B10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"2021072816523306800_fmab030-B11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"2021072816523306800_fmab030-B12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02725650","article-title":"Can throat swab after physiotherapy replace sputum for identification of microbial pathogens in children with cystic fibrosis?","volume":"71","author":"Kabra","year":"2004","journal-title":"Indian J Ped"},{"key":"2021072816523306800_fmab030-B13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic fibrosis foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2021072816523306800_fmab030-B14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thx.2009.121657","article-title":"Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial","volume":"65","author":"Ratjen","year":"2010","journal-title":"Thorax"},{"key":"2021072816523306800_fmab030-B15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2180-5-43","article-title":"Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India","volume":"5","author":"Agarwal","year":"2005","journal-title":"BMC Microbiol"},{"key":"2021072816523306800_fmab030-B16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ppul.10100","article-title":"Predictors of deterioration of lung function in cystic fibrosis","volume":"33","author":"Schaedel","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"2021072816523306800_fmab030-B17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2011.06.002","article-title":"Review: Staphylococcus aureus and MRSA in cystic fibrosis","volume":"10","author":"Goss","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2021072816523306800_fmab030-B18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/ppul.20914","article-title":"The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis","volume":"43","author":"Sawicki","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"2021072816523306800_fmab030-B19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ppul.20604","article-title":"Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function","volume":"42","author":"Ren","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"2021072816523306800_fmab030-B20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pcl.2016.04.003","article-title":"Cystic fibrosis: microbiology and host response","volume":"63","author":"Zemanick","year":"2016","journal-title":"Pediatr Clin North Am"},{"key":"2021072816523306800_fmab030-B21","first-page":"1","volume-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection","author":"Agudelo","year":"2014"},{"key":"2021072816523306800_fmab030-B22","first-page":"356","article-title":"Emergence of vancomycin-resistant Enterococcus faecium after use of inhaled vancomycin in a cystic fibrosis patient chronically infected with methicillin-resistant Staphylococcus aureus","volume":"6","author":"da Silva Filho","year":"2008","journal-title":"Einstein"},{"key":"2021072816523306800_fmab030-B23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1378\/chest.09-2996","article-title":"Sputum Candida albicans presages FEV1 decline and hospital-treated exacerbations in cystic fibrosis","volume":"138","author":"Chotirmall","year":"2010","journal-title":"Chest"},{"key":"2021072816523306800_fmab030-B24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ppul.23302","article-title":"Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis","volume":"50","author":"Gileles-Hillel","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2021072816523306800_fmab030-B25","first-page":"DC20","article-title":"Inducible clindamycin resistance among clinical isolates of Staphylococcus aureus from Sub Himalayan Region of India","volume":"9","author":"Mokta","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"2021072816523306800_fmab030-B26","first-page":"571","article-title":"Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus","volume":"123","author":"Gadepalli","year":"2006","journal-title":"Indian J Med Res"},{"key":"2021072816523306800_fmab030-B27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"D\u00f6ring","year":"2000","journal-title":"Eur Respir J"},{"key":"2021072816523306800_fmab030-B28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.44.3.710-712.2000","article-title":"Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"44","author":"Jalal","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2021072816523306800_fmab030-B29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/thorax.58.9.794","article-title":"Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents","volume":"58","author":"Pitt","year":"2003","journal-title":"Thorax"}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/tropej\/article-pdf\/67\/2\/fmab030\/39354998\/fmab030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/tropej\/article-pdf\/67\/2\/fmab030\/39354998\/fmab030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T16:54:09Z","timestamp":1627491249000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tropej\/article\/doi\/10.1093\/tropej\/fmab030\/6294507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmab030","relation":{},"ISSN":["0142-6338","1465-3664"],"issn-type":[{"value":"0142-6338","type":"print"},{"value":"1465-3664","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,4,1]]},"article-number":"fmab030"}}